A Blueprint for Advocacy in Neonatology.


Journal

NeoReviews
ISSN: 1526-9906
Titre abrégé: Neoreviews
Pays: United States
ID NLM: 101085360

Informations de publication

Date de publication:
01 02 2022
Historique:
entrez: 1 2 2022
pubmed: 2 2 2022
medline: 23 3 2022
Statut: ppublish

Résumé

Advocacy is at the heart of pediatrics and neonatal care. Historically and currently, numerous pediatricians have used their expertise to raise the voices of children and families to promote child health and welfare. Despite a lack of formal training in advocacy and health policy, many of the skills required for daily clinical care can, and ought to, be applied to affect systemic change within neonatology. Advocacy can no longer be considered an optional activity, but rather a core competency and professional responsibility. In this review, the authors describe the necessity and foundational principles for advocacy success as well as provide guidance, resources, and opportunities for neonatologists and clinicians providing newborn care.

Identifiants

pubmed: 35102381
pii: 184638
doi: 10.1542/neo.23-2-e74
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e74-e81

Informations de copyright

Copyright © 2022 by the American Academy of Pediatrics.

Auteurs

Dena K Hubbard (DK)

Division of Neonatology, Department of Pediatrics, Children's Mercy-Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, MO.

Ladawna Gievers (L)

Division of Neonatology, Department of Pediatrics, Oregon Health and Science University, Portland, OR.

Karishma Rao (K)

Division of Neonatology, Department of Pediatrics, Children's Mercy-Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, MO.

John A F Zupancic (JAF)

Department of Neonatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Benjamin D Hoffman (BD)

Division of General Pediatrics, Department of Pediatrics, Oregon Health and Science University, Portland, OR.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH